Abstract |
The role of surgical revascularization for patients who have ischemic disease remains controversial. Despite the previous EC-IC bypass trial that failed to demonstrate the benefit from STA-MCA bypass compared with medical therapy, however, there is mounting evidence that the procedure should be considered in selected patients. Bypass remains a mainstay of treatment in moyamoya disease and in flow replacement in the setting of planned vessel sacrifice.
|
Authors | Sepideh Amin-Hanjani, Fady T Charbel |
Journal | Neurologic clinics
(Neurol Clin)
Vol. 24
Issue 4
Pg. 729-43
(Nov 2006)
ISSN: 0733-8619 [Print] United States |
PMID | 16935199
(Publication Type: Journal Article, Review)
|
Topics |
- Brain
(blood supply)
- Brain Diseases
(surgery)
- Cerebral Angiography
- Cerebral Revascularization
(methods)
- Clinical Trials as Topic
- Humans
- Neurosurgical Procedures
(methods)
- Vascular Surgical Procedures
(methods)
|